BioLife Solutions, Inc.
BioLife Solutions, Inc. (BLFS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BLFS · as of Jun 8, 2026
Key Statistics
Explore BioLife Solutions, Inc. Data
blfs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 100.0%
The BLFS analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $34.00, representing +26.03% upside from the current price of $26.98.
Competitors & Peers
blfs competitorsBLFS
ATRC
AZTA
ESTA
HROW
KMTSStock Performance
Full HistoryAbout BioLife Solutions, Inc.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and …
what is biolife solutions, inc. · blfs stock overview · biolife solutions, inc. company profile · who is biolife solutions, inc. ceo · blfs NASDAQ · biolife solutions, inc. headquarters · biolife solutions, inc. business segments
About Stock Overview & Key Data
BioLife Solutions, Inc. (BLFS) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NASDAQ since Nov 22, 1989. As of the latest trading session, BLFS stock price is $26.98, with a market capitalization of $1.3B. The stock has returned +11.74% over the past 12 months and +10.17% year-to-date.
According to 17 Wall Street analysts, the consensus rating for BioLife Solutions, Inc. stock is Buy, with an average 12-month price target of $34.00. In fiscal year 2025, BioLife Solutions, Inc. reported revenue of $96.2M and net income of -$12.1M. For detailed data — including BioLife Solutions, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioLife Solutions, Inc. (BLFS) stock price is $26.98. The stock is traded on NASDAQ under the ticker symbol BLFS. The 52-week range is $17.86 – $29.62.